NO890029D0 - Nye modifiserte peptider og proteiner for in vitro diagnoser (diabetes). - Google Patents

Nye modifiserte peptider og proteiner for in vitro diagnoser (diabetes).

Info

Publication number
NO890029D0
NO890029D0 NO890029A NO890029A NO890029D0 NO 890029 D0 NO890029 D0 NO 890029D0 NO 890029 A NO890029 A NO 890029A NO 890029 A NO890029 A NO 890029A NO 890029 D0 NO890029 D0 NO 890029D0
Authority
NO
Norway
Prior art keywords
signal
haemoglobin
pct
bound
sample
Prior art date
Application number
NO890029A
Other languages
English (en)
Norwegian (no)
Inventor
Erling Sundrehagen
Original Assignee
Axis Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Axis Research filed Critical Axis Research
Priority to NO890029A priority Critical patent/NO890029D0/no
Publication of NO890029D0 publication Critical patent/NO890029D0/no
Priority to NO891929A priority patent/NO891929D0/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G01N33/539—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody involving precipitating reagent, e.g. ammonium sulfate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721—Haemoglobin
    • G01N33/723—Glycosylated haemoglobin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/824—Immunological separation techniques
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25125—Digestion or removing interfering materials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • External Artificial Organs (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO890029A 1989-01-04 1989-01-04 Nye modifiserte peptider og proteiner for in vitro diagnoser (diabetes). NO890029D0 (no)

Priority Applications (2)

Application Number Priority Date Filing Date Title
NO890029A NO890029D0 (no) 1989-01-04 1989-01-04 Nye modifiserte peptider og proteiner for in vitro diagnoser (diabetes).
NO891929A NO891929D0 (no) 1989-01-04 1989-05-11 Nye komposisjoner med loeselige signalmolekyler for in vitro overvaaking av diabetes mellitus.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NO890029A NO890029D0 (no) 1989-01-04 1989-01-04 Nye modifiserte peptider og proteiner for in vitro diagnoser (diabetes).
NO891929A NO891929D0 (no) 1989-01-04 1989-05-11 Nye komposisjoner med loeselige signalmolekyler for in vitro overvaaking av diabetes mellitus.

Publications (1)

Publication Number Publication Date
NO890029D0 true NO890029D0 (no) 1989-01-04

Family

ID=19892012

Family Applications (4)

Application Number Title Priority Date Filing Date
NO890029A NO890029D0 (no) 1989-01-04 1989-01-04 Nye modifiserte peptider og proteiner for in vitro diagnoser (diabetes).
NO891929A NO891929D0 (no) 1989-01-04 1989-05-11 Nye komposisjoner med loeselige signalmolekyler for in vitro overvaaking av diabetes mellitus.
NO901643A NO901643D0 (no) 1989-05-11 1990-04-11 Ligand bindingstest med signalgivende molekyl for spesifikk kvantifisering av glykosylert hemoglobin i blandinger inneholdende andre glykosylerte proteiner og/eller glykoproteiner og/eller karbohydrater.
NO914372A NO302784B1 (no) 1989-05-11 1991-11-08 Fremgangsmåte ved påvisning av glykosylert hemoglobin samt sett og reagens for utförelse av fremgangsmåten

Family Applications After (3)

Application Number Title Priority Date Filing Date
NO891929A NO891929D0 (no) 1989-01-04 1989-05-11 Nye komposisjoner med loeselige signalmolekyler for in vitro overvaaking av diabetes mellitus.
NO901643A NO901643D0 (no) 1989-05-11 1990-04-11 Ligand bindingstest med signalgivende molekyl for spesifikk kvantifisering av glykosylert hemoglobin i blandinger inneholdende andre glykosylerte proteiner og/eller glykoproteiner og/eller karbohydrater.
NO914372A NO302784B1 (no) 1989-05-11 1991-11-08 Fremgangsmåte ved påvisning av glykosylert hemoglobin samt sett og reagens for utförelse av fremgangsmåten

Country Status (16)

Country Link
US (1) US5242842A (ko)
EP (1) EP0471774B1 (ko)
JP (1) JPH0812196B2 (ko)
KR (1) KR960010697B1 (ko)
AT (1) ATE117806T1 (ko)
AU (1) AU642879B2 (ko)
BR (1) BR9007357A (ko)
CA (1) CA2055430C (ko)
DE (1) DE69016423T2 (ko)
DK (1) DK0471774T3 (ko)
ES (1) ES2067029T3 (ko)
FI (1) FI100437B (ko)
HU (1) HU215181B (ko)
NO (4) NO890029D0 (ko)
RU (1) RU2111494C1 (ko)
WO (1) WO1990013818A1 (ko)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5807747A (en) * 1989-06-13 1998-09-15 Clinical Innovations Limited Method and apparatus for determination of glycosylated protein
US5403745A (en) * 1990-04-27 1995-04-04 Genzyme Corporation Determination of analytes in biological fluids in the presence of substances interfering with assays therefor
US5135875A (en) * 1990-08-15 1992-08-04 Abbott Laboratories Protein precipitation reagent
GB9024771D0 (en) * 1990-11-14 1991-01-02 Axis Research Assay
GB9024775D0 (en) * 1990-11-14 1991-01-02 Axis Research Chemical compounds
DE4206932A1 (de) * 1992-03-05 1993-09-09 Boehringer Mannheim Gmbh Immunologische methode zur bestimmung eines haemoglobinderivates
US5512451A (en) * 1993-04-01 1996-04-30 British Technology Group Limited Enhancement of chemiluminescent reactions
US5837878A (en) * 1994-01-28 1998-11-17 Prolinx, Inc. Boronic compound complexing reagents and highly stable complexes
US5852178A (en) * 1994-01-28 1998-12-22 Prolinx, Inc. Phenylboronic acid complexing reagents for conjugating biologically active molecules
RU2202555C2 (ru) * 1994-01-28 2003-04-20 Пролинкс, Инк. Биоконъюгационные комплексы, способы их получения (варианты), фенилборнокислые комплексообразующие реагенты, фенилборнокислые поперечно-сшивающие реагенты, набор средств или система, способ выделения требуемой популяции клеток
US5594151A (en) * 1994-01-28 1997-01-14 Prolinx, Inc. Phenylboronic acid complexing reagents derived from aminosalicylic acid
US5777148A (en) * 1994-01-28 1998-07-07 Prolinx, Inc. Boronic compound complexing reagents and highly stable complexes
US5847192A (en) * 1994-01-28 1998-12-08 Prolinx, Inc. Boronic compound complexing reagents and complexes
US5594111A (en) * 1994-01-28 1997-01-14 Prolinx, Inc. Phenylboronic acid complexes for bioconjugate preparation
US5744627A (en) * 1994-01-28 1998-04-28 Prolinx, Inc. Boronic compound complexing reagents and complexes
US5623055A (en) * 1994-01-28 1997-04-22 Prolinx, Inc. Phenylboronic acid complexes derived from aminosalicylic acid for bioconjugate preparation
US5631364A (en) * 1994-03-31 1997-05-20 Axis Biochemicals Asa Labelled boronic acid derivatives
GB9415143D0 (en) * 1994-07-27 1994-09-14 Edwards Raymond Glycated haemoglobin assay
AU3953595A (en) * 1994-10-07 1996-05-02 Merck & Co., Inc. Process for assessing tubulin protein polymerization
US5695949A (en) * 1995-04-07 1997-12-09 Lxn Corp. Combined assay for current glucose level and intermediate or long-term glycemic control
GB9508278D0 (en) * 1995-04-24 1995-06-14 Axis Biochemicals As Haemoglobin standards
JP3269765B2 (ja) * 1995-12-14 2002-04-02 富士写真フイルム株式会社 ヘモグロビン誘導体の免疫学的測定方法及びその方法に用いる処理試薬
US6001573A (en) * 1996-06-14 1999-12-14 Packard Bioscience B.V. Use of porphyrins as a universal label
US6075126A (en) 1996-08-05 2000-06-13 Prolinx, Inc. Phenyldiboronic acid reagents and complexes
US6156884A (en) 1996-08-05 2000-12-05 Prolinx, Inc. Bifunctional boronic compound complexing reagents and complexes
US6316265B1 (en) 1997-03-13 2001-11-13 Abbott Laboratories Determination of % glycated hemoglobin
US6162645A (en) * 1997-03-13 2000-12-19 Abbott Laboratories Determination of % glycated hemoglobin
DE19843094A1 (de) 1998-09-21 2000-03-23 Roche Diagnostics Gmbh Verfahren zur Bestimmung von glykiertem Hämoglobin
DE19856433C2 (de) * 1998-12-08 2001-09-13 Aventis Behring Gmbh Verfahren zum spezifischen Nachweis von glykosilierten Proteinen
US7470420B2 (en) * 2000-12-05 2008-12-30 The Regents Of The University Of California Optical determination of glucose utilizing boronic acid adducts
US6653141B2 (en) 2000-12-05 2003-11-25 The Regents Of The University Of California Polyhydroxyl-substituted organic molecule sensing method and device
US6627177B2 (en) 2000-12-05 2003-09-30 The Regents Of The University Of California Polyhydroxyl-substituted organic molecule sensing optical in vivo method utilizing a boronic acid adduct and the device thereof
US7195923B2 (en) * 2001-01-31 2007-03-27 Scripps Laboratories, Inc. Ratiometric determination of glycated protein
GB0110053D0 (en) * 2001-04-24 2001-06-13 Axis Shield Asa Assay
US6852503B1 (en) * 2001-05-30 2005-02-08 Pierce Biotechnology, Inc. Compositions and methods for utilizing mixed substrate solutions of luminols and dioxetanes
AU2003291250A1 (en) * 2002-11-05 2004-06-07 Therasense, Inc. Assay device, system and method
US7390670B2 (en) * 2003-02-20 2008-06-24 Lumigen, Inc. Signalling compounds and methods for detecting hydrogen peroxide
AU2005203321A1 (en) * 2004-08-03 2006-02-23 Axis-Shield Diagnostics Limited Assay
AU2006240568A1 (en) * 2005-04-25 2006-11-02 Philera New Zealand Limited Copper regulation evaluation and therapy
GB2436681B (en) * 2006-03-31 2010-10-13 Quotient Diagnostics Ltd Fluorescent assay
WO2007127616A2 (en) * 2006-04-12 2007-11-08 Benjamin Pless Cavitation heating system and method
EP2047272B1 (en) * 2006-07-29 2014-10-22 i-Sens, Inc. Electrochemical determination system of glycated proteins
KR101005559B1 (ko) 2008-07-15 2011-01-05 주식회사 아이센스 바이오센서를 이용한 단백질 측정 장치
EP2359146A1 (en) * 2008-10-14 2011-08-24 Piramal Healthcare Limited Non-enzymatic electrochemical method for simultaneous determination of total hemoglobin and glycated hemoglobin
WO2010147251A1 (ko) 2009-06-19 2010-12-23 주식회사 인포피아 당화혈색소 측정 방법
JP6335792B2 (ja) * 2012-01-16 2018-05-30 コーニンクレッカ フィリップス エヌ ヴェＫｏｎｉｎｋｌｉｊｋｅ Ｐｈｉｌｉｐｓ Ｎ．Ｖ． 細胞を含む体液における標的分子の存在の決定
GB201215571D0 (en) * 2012-08-31 2012-10-17 Axis Shield Asa Assay method
KR20140032221A (ko) * 2012-09-06 2014-03-14 삼성전자주식회사 시료 중의 당화 단백질을 확인하는 방법 및 그를 위한 장치
RU2612092C1 (ru) * 2015-12-08 2017-03-02 Федеральное государственное бюджетное учреждение "Российский кардиологический научно-производственный комплекс" Министерства здравоохранения Российской Федерации (ФГБУ "РКНПК" Минздрава России) Способ диагностики сахарного диабета по уровню метилглиоксаль-модифицированных липопротеидов низкой плотности с использованием моноклональных антител
CN107153121B (zh) * 2017-04-12 2019-03-08 深圳市东邦生物医疗技术有限公司 糖化血红蛋白、血红蛋白检测试剂盒及其检测方法
CN115825293B (zh) * 2023-02-21 2023-10-13 艾康生物技术(杭州)有限公司 一种用于糖化血红蛋白测试的试剂盒

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4269605A (en) * 1978-06-28 1981-05-26 Amicon Corporation Method and kit for separation of glycoproteins
US4268270A (en) * 1979-04-30 1981-05-19 Children's Hospital Medical Center Glycosylated hemoglobin measurement
FR2464475A1 (fr) * 1979-08-30 1981-03-06 Amicon Corp Procede et produit pour la separation des glycoproteines et leur application notamment a la determination de l'hemoglobine glycosylee
JPS5640694A (en) * 1979-09-06 1981-04-16 Amicon Corp Method of separating glycoprotein and chemical agent therefor
US4371374A (en) * 1980-11-17 1983-02-01 The Rockefeller University Monitoring metabolic control in diabetic patients by measuring glycosylated amino acids and peptides in urine
US4407961A (en) * 1981-03-16 1983-10-04 Sanders James L Ion-exchange system and method for isolation and determination of glycosylated hemoglobin in human blood
US4659817A (en) * 1981-05-01 1987-04-21 The Children's Medical Center Corporation Reporter compounds containing boron
GB8504521D0 (en) * 1985-02-21 1985-03-27 Genetics Int Inc Electrochemical assay
US4861728A (en) * 1987-07-24 1989-08-29 Becton, Dickinson And Company Immunoassay of glycosylated hemoglobin using a labeled boron reagent
US5137833A (en) * 1989-09-21 1992-08-11 Russell Anthony P Method for detecting polyhydroxyl compounds

Also Published As

Publication number Publication date
NO901643D0 (no) 1990-04-11
RU2111494C1 (ru) 1998-05-20
EP0471774A1 (en) 1992-02-26
WO1990013818A1 (en) 1990-11-15
FI915284A0 (fi) 1991-11-08
KR920701824A (ko) 1992-08-12
EP0471774B1 (en) 1995-01-25
AU642879B2 (en) 1993-11-04
KR960010697B1 (ko) 1996-08-07
HU904320D0 (en) 1992-02-28
NO914372D0 (no) 1991-11-08
ATE117806T1 (de) 1995-02-15
HUT66835A (en) 1995-01-30
FI100437B (fi) 1997-11-28
NO914372L (no) 1992-01-09
DE69016423D1 (de) 1995-03-09
AU5667090A (en) 1990-11-29
NO302784B1 (no) 1998-04-20
BR9007357A (pt) 1992-04-21
DK0471774T3 (da) 1995-03-20
US5242842A (en) 1993-09-07
DE69016423T2 (de) 1995-06-14
CA2055430A1 (en) 1990-11-12
HU215181B (hu) 1998-10-28
JPH04506703A (ja) 1992-11-19
NO891929D0 (no) 1989-05-11
ES2067029T3 (es) 1995-03-16
CA2055430C (en) 1999-08-31
JPH0812196B2 (ja) 1996-02-07

Similar Documents

Publication Publication Date Title
NO890029D0 (no) Nye modifiserte peptider og proteiner for in vitro diagnoser (diabetes).
ES2061273T3 (es) Ensayo para proteinas glicadas de la sangre.
Brennan Changes in solubility, non-enzymatic glycation, and fluorescence of collagen in tail tendons from diabetic rats
ATE161960T1 (de) Isolierung von fetalen zellen aus mütterlichem blut zur ausführung von pränataler diagnostik
DK0429612T3 (da) Fremgangsmåde til optisk analyse
EP0752426A2 (de) Synthetische Kalibratoren für den Einsatz in Immunoassays, bestehend aus Analyten oder Teilsequenzen davon, die an inerte Trägermoleküle konjugiert sind
ATE186403T1 (de) Verfahren und testgerät zum nachweis von freiem igfbp-1
DK0729517T3 (da) Fremgangsmåde til opnåelse af diagnostiske reagenser, assays og terapeutiske midler baseret på kliniske udtryk af en sygdom
CA2235316A1 (en) A method for detecting antipolymer antibodies and a diagnostic test kit for use in aiding the diagnosis of silicone related diseases (srd)
EP2060631A3 (en) Characterization of granulocytic ehrlichia and methods of use
ATE210825T1 (de) Küvette für eine analysevorrichtung, verfahren und diagnostischer testsatz zur feststellung von analyten in vollblutproben
WO2001057537A3 (en) Methods for diagnosis of alzheimer's disease
ATE225511T1 (de) Entstörung von diagnostischen verfahren durch peptide aus d-aminosäuren
Nelson et al. Preparation and characterization of diaspirin cross-linked hemoglobin solutions for preclinical studies
KR940005666A (ko) C형 간염 바이러스를 분류하기 위한 항원성 펩티드 ,이 펩티드를 포함하는 키트 및 이 펩티드를 사용하여 c형 간염 바이러스를 분류하는 방법
MXPA03009778A (es) Pepetido de union de anticuerpos de la enfermedad de crohn y metodo de examinar la enfermedad de crohn.
Vestling Insulin: HPLC mapping of protease digestion products: A biochemistry laboratory experiment
JP2000065839A (ja) ヒトヘモグロビン検出装置
Golbey Enzymology in the practice of laboratory medicine
JPS6486067A (en) Diagnosis and kit for bloom syndrome
UA51131A (uk) Спосіб діагностики аутоімунних захворювань печінки